The cell and gene therapy (CGT) market is poised to witness a significant upsurge, and is expected to grow from USD 25.03 billion in 2025 to around USD 117.46 billion by 2034. This reflects a compound annual growth rate of 18.7 percent. Furthermore, this expansion is driven by factors such as the rising number of regulatory approvals, technological advancements, and increased investments in research and development. Also to note, the diversification of therapy applications encompasses beyond oncology, so as to address a wider range of diseases, today.
With this burgeoning... >>More
Vinay Jain, Chief Operating Officer, Onelife Nutriscience
Rashmi Pimpale, CEO, Research and Innovation Circle of Hyderabad (RICH)
Vivek Soares, Country Lead, India and South Asia, Organon
Dr. S Eswara Reddy, Joint Drugs Controller (India), Central Drugs Standard Control Organisation (CDSCO)
Nishi Sharma, Associate Vice President (Digital Governance), Alpha MD
Dr. Bimal Chhajer, Director, SAAOL Heart Center
Shripad Joshi, President - India & South Asia, Revvity
Nitin Gupta, MD, FUJIFILM Sonosite India
